tranexamic acid has been researched along with Cerebral Infarction in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We enrolled 479 patients with subarachnoid hemorrhage in a multicenter, randomized, double-blind, placebo-controlled trial to determine whether treatment with the antifibrinolytic agent tranexamic acid improves outcome by preventing rebleeding." | 5.05 | Antifibrinolytic treatment in subarachnoid hemorrhage. ( Cheah, F; Hijdra, A; Lindsay, KW; Muizelaar, JP; Murray, GD; Schannong, M; Teasdale, GM; van Crevel, H; van Gijn, J; Vermeulen, M, 1984) |
| "Tranexamic acid has been shown to reduce perioperative blood loss without increasing the risk of venous thromboembolism after total knee replacement." | 1.39 | Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. ( Baker, J; Bruce-Brand, R; Dragomir, R; Harty, J, 2013) |
| "We studied 471 consecutive patients with aneurysmal subarachnoid hemorrhage and used logistic regression with step-wise forward selection of variables." | 1.29 | Amount of blood on computed tomography as an independent predictor after aneurysm rupture. ( Brouwers, PJ; Dippel, DW; Hasan, D; Lindsay, KW; van Gijn, J; Vermeulen, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Post, R | 1 |
| Germans, MR | 1 |
| Coert, BA | 1 |
| Rinkel, GJE | 1 |
| Vandertop, WP | 1 |
| Verbaan, D | 1 |
| Bruce-Brand, R | 1 |
| Dragomir, R | 1 |
| Baker, J | 1 |
| Harty, J | 1 |
| Vermeulen, M | 3 |
| Lindsay, KW | 3 |
| Murray, GD | 2 |
| Cheah, F | 1 |
| Hijdra, A | 2 |
| Muizelaar, JP | 2 |
| Schannong, M | 1 |
| Teasdale, GM | 2 |
| van Crevel, H | 2 |
| van Gijn, J | 3 |
| Brouwers, PJ | 1 |
| Dippel, DW | 1 |
| Hasan, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage. A Prospective, Randomized, Multicenter Study.[NCT02684812] | Phase 2/Phase 3 | 955 participants (Actual) | Interventional | 2012-07-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for tranexamic acid and Cerebral Infarction
| Article | Year |
|---|---|
Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
Topics: Adult; Antifibrinolytic Agents; Cerebral Infarction; Clinical Trials, Phase II as Topic; Clinical Tr | 2020 |
Antifibrinolytic treatment in subarachnoid hemorrhage.
Topics: Cerebral Angiography; Cerebral Infarction; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Do | 1984 |
Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.
Topics: Age Factors; Aged; Aged, 80 and over; Cerebral Infarction; Cyclohexanecarboxylic Acids; Double-Blind | 1988 |
2 other studies available for tranexamic acid and Cerebral Infarction
| Article | Year |
|---|---|
Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cerebral Infar | 2013 |
Amount of blood on computed tomography as an independent predictor after aneurysm rupture.
Topics: Age Factors; Aged; Aneurysm, Ruptured; Blood; Cerebral Infarction; Double-Blind Method; Glasgow Coma | 1993 |